companydata.dkcompanydata.dk

Ranger Biotechnologies A/S: Financial statements 2025

CVR: 32280404

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Ranger Biotechnologies A/S (CVR 32280404) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273. The solvency ratio was 94.1%. The company had 1 employee in the financial year.

Gross Profit
DKK -409,444
Profit/Loss
DKK -843,419
Equity
DKK 711,273
Total Assets
DKK 755,511
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--409K-843K711K1
2024--224K-1.1M1.6M1
2023-1.7M1.4M2.7M0
2022-7.1M372K1.3M11
2021-5.7M172K889K9

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Ranger Biotechnologies A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Ranger Biotechnologies A/S: The 2024 annual report is outJun 30, 2025

Ranger Biotechnologies A/S has published its annual report for 2024. Gross profit came to DKK -223,697, and the net result was DKK -1,138,092.

About Ranger Biotechnologies A/S

Ranger Biotechnologies A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MIRRX THERAPEUTICS A/S and MIRX THERAPEUTICS A/S. The management consists of Hans Thorleif Møller. The board consists of Christina Møller Udesen (chair), Hans Thorleif Møller, Kasper Tvede Larsen and Søren Tvede Larsen. The company is owned by QUERDENKER ApS and Outlate Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273.

Source: annual report 2025, Danish Business Authority